Vaccine to treat cervical cancer shows early promise

CHICAGO (Reuters) – A new type of cervical cancer vaccine made by Inovio Pharmaceuticals has shown early promise as a potential treatment for pre-cancerous changes in the cervix, researchers at the company said on Wednesday. Instead of preventing infections caused by certain strains of the human papillomavirus or HPV, as is the aim of Merck’s Gardasil and GlaxoSmithKline’s Cervarix vaccine, the Inovio vaccine is designed to train the immune system to kill cells that spur cancer growth in women who are already infected. …
Sexual Health News Headlines – Yahoo! News